number of downloads : ?
File
language
eng
Author
Tanaka, Sayuri Department of Internal Medicine 1, Shimane University Faculty of Medicine
Kanazawa, Ippei Department of Internal Medicine 1, Shimane University Faculty of Medicine
Notsu, Masakazu Department of Internal Medicine 1, Shimane University Faculty of Medicine
Sugimoto, Toshitsugu Department of Internal Medicine 1, Shimane University Faculty of Medicine
Description
OBJECTIVE: The relationship between serum DPP-4 level and visceral fat mass is still unclear in type 2 diabetes mellitus (T2DM). This study thus aimed to examine the association of visceral fat accumulation and metabolic syndrome with serum DPP-4 levels in T2DM.
METHODS: Visceral and subcutaneous fat areas were evaluated by performing computed tomography scan in 135 men with T2DM, who had never taken DPP-4 inhibitors or GLP-1 receptor agonists. We investigated the association between serum DPP-4 levels and visceral fat area as well as the presence of metabolic syndrome.
RESULTS: Multiple regression analysis adjusted for age, duration of T2DM, body mass index, serum creatinine, and HbA1c showed that serum DPP-4 levels were positively associated with visceral fat area (β=0.25, p=0.04), but not subcutaneous fat area (β=-0.18, p=0.13). In logistic regression analyses adjusted for the confounding factors described above, serum DPP-4 levels were positively associated with visceral fat obesity and metabolic syndrome [odds ratio (OR)=1.63, 95% confidence interval (CI)=1.00-2.66 per standard deviation (SD) increase, p=0.04; OR=1.77, 95%CI=1.09-2.88 per SD increase, p=0.02, respectively].
CONCLUSIONS: The present study showed that serum DPP-4 level was positively and specifically associated with accumulation of visceral fat and the presence of metabolic syndrome in men with T2DM.
Subject
Dipeptidyl peptidase-4
Visceral fat
Metabolic syndrome
Type 2 diabetes mellitus
Journal Title
Diabetes research and clinical practice
Volume
116
Start Page
1
End Page
6
ISSN
01688227
Published Date
2016-06
DOI
DOI Date
2017-07-18
PubMed ID
NCID
AA1044374X
Publisher
Elsevier
NII Type
Journal Article
Format
PDF
Rights
© 2016 Elsevier Ireland Ltd. All rights reserved.
Text Version
著者版
Gyoseki ID
e31960
OAI-PMH Set
Faculty of Medicine
このエントリーをはてなブックマークに追加